This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Novo Nordisk has a GLP-1 Ozempic pill. That's both good and bad news for Novo No...
The data is bad, but stocks are up anyway.
Patrice Louvet doesn’t believe in sugar coating criticism: “If there's a big iss...
U.S. stocks rebounded strongly Tuesday after a brutal start to the week, even as...
Wall Street veteran Mintzberg has been lying low in the first year on the job. T...
MSCI delivered better-than-expected earnings and revenue in its latest quarter d...